A recent study indicates that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional lifestyle plans.
Findings released in a leading health publication points out that while obese people often shed a large proportion of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users using such medications need to be informed of the risk of rapid weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
Such speed of recovery suggests a reversion to pre-treatment mass within about 18 months.
Comparing Treatments
The research, which reviewed 37 of studies involving thousands of patients, compared the effects of the injectable medications with older methods.
Scientists emphasize that individuals who shed pounds through diet and exercise generally see a slower creep back—around 100 grams monthly—once they finish.
Understanding the Quick Regain
Doctors believe the mechanism of the drugs accounts for the heightened regain.
GLP-1 drugs copy a body's own chemical called GLP-1, which moderates hunger.
"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating a significant risk."
A Chronic Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of weight regain, the therapy might need to be life-long.
This view is reinforced by pharmaceutical companies, who state that the findings "underscore the long-term nature of obesity," comparing it to managing diseases like hypertension.
Patient Experiences
People who have stopped the jabs report a powerful return of cravings.
"I experienced a switch flipping and you're instantly ravenous," described one woman.
This difficulty is exacerbated if patients have not developed lasting lifestyle or habit modifications during treatment.
Growing Interest
Figures indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is higher among females compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a standalone solution and maintained weight loss hinges on combined lifestyle management.
